These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11901927)

  • 21. [Barrett's esophagus and Helicobacter pylori].
    Sakata H; Fujimoto K
    Nihon Rinsho; 2005 Aug; 63(8):1383-6. PubMed ID: 16101226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
    Ekiz F; Ormeci N; Coban S; Karabulut HG; Aktas B; Tukun A; Tuncali T; Yüksel O; Alkış N
    Dis Esophagus; 2012 Jul; 25(5):437-41. PubMed ID: 21951971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies.
    Salminen JT; Rämö OJ; Ahotupa MO; Färkkilä MA; Salo JA
    Ann Med; 2002; 34(7-8):565-70. PubMed ID: 12553496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenocarcinoma of the esophagus complicating Cornelia de Lange syndrome.
    DuVall GA; Walden DT
    J Clin Gastroenterol; 1996 Mar; 22(2):131-3. PubMed ID: 8742653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular targets for treatment of Barrett's esophagus.
    Feagins LA; Souza RF
    Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
    Ek WE; Levine DM; D'Amato M; Pedersen NL; Magnusson PK; Bresso F; Onstad LE; Schmidt PT; Törnblom H; Nordenstedt H; Romero Y; ; Chow WH; Murray LJ; Gammon MD; Liu G; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Ye W; Wu AH; Zucchelli M; Spector TD; Hysi P; Vaughan TL; Whiteman DC; MacGregor S;
    J Natl Cancer Inst; 2013 Nov; 105(22):1711-8. PubMed ID: 24168968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma.
    Fitzgerald RC
    Clin Gastroenterol Hepatol; 2005 Jun; 3(6):529-37. PubMed ID: 15952094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of the complications of gastroesophageal reflux disease.
    Belhocine K; Galmiche JP
    Dig Dis; 2009; 27(1):7-13. PubMed ID: 19439954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Schneider JL; Corley DA
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):353-364. PubMed ID: 28577761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of transcription factor in Barrett's esophagus].
    Mutoh H
    Nihon Rinsho; 2005 Aug; 63(8):1367-71. PubMed ID: 16101223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
    Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
    Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus.
    Gharahkhani P; Tung J; Hinds D; Mishra A; ; Vaughan TL; Whiteman DC; MacGregor S;
    Hum Mol Genet; 2016 Feb; 25(4):828-35. PubMed ID: 26704365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
    Gastroenterology; 2001 Dec; 121(6):1281-5. PubMed ID: 11729106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial Barrett's esophagus associated with adenocarcinoma.
    Jochem VJ; Fuerst PA; Fromkes JJ
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1400-2. PubMed ID: 1551547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barrett's esophagus: what do we really know about this disease?
    Fennerty MB
    Am J Gastroenterol; 1997 Jan; 92(1):1-3. PubMed ID: 8995929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.